Literature DB >> 33500360

Functional Hierarchy and Cooperation of EMT Master Transcription Factors in Breast Cancer Metastasis.

Joseph B Addison1, Maria A Voronkova1, James H Fugett1, Chen-Chung Lin1, Nathaniel C Linville1, Brandon Trinh1, Ryan H Livengood2, Matthew B Smolkin2, Michael D Schaller1, J Michael Ruppert1, Elena N Pugacheva1, Chad J Creighton3, Alexey V Ivanov4.   

Abstract

Several master transcription factors (TF) can activate the epithelial-to-mesenchymal transition (EMT). However, their individual and combinatorial contributions to EMT in breast cancer are not defined. We show that overexpression of EMT-TFs individually in epithelial cells upregulated endogenous SNAI2, ZEB1/2, TCF4, and TWIST1/2 as a result of positive feedback mediated in part by suppression of their negative regulator miRNAs miR200s/203/205. We identified TCF4 as a potential new target of miR200s. Expression of ZEB1/2 strongly correlated with the mesenchymal phenotype in breast cancer cells, with the CD24-/CD44+ stemness profile, and with lower expression of core epithelial genes in human breast tumors. Knockdown of EMT-TFs identified the key role of ZEB1 and its functional cooperation with other EMT-TFs in the maintenance of the mesenchymal state. Inducible ZEB1+2 knockdown in xenograft models inhibited pulmonary metastasis, emphasizing their critical role in dissemination from primary site and in extravasation. However, ZEB1+2 depletion one-week after intravenous injection did not inhibit lung colonization, suggesting that ZEB1/2 and EMT are not essential for macrometastatic outgrowth. These results provide strong evidence that EMT is orchestrated by coordinated expression of several EMT-TFs and establish ZEB1 as a key master regulator of EMT and metastasis in breast cancer. IMPLICATIONS: The EMT program is orchestrated by coordinated expression of multiple EMT transcription factors, whereas ZEB1 integrates the EMT master regulatory network and plays the major role in promoting EMT and metastasis. ©2021 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33500360      PMCID: PMC8137545          DOI: 10.1158/1541-7786.MCR-20-0532

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   6.333


  60 in total

Review 1.  Epithelial-mesenchymal transitions in development and disease.

Authors:  Jean Paul Thiery; Hervé Acloque; Ruby Y J Huang; M Angela Nieto
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

2.  Genetic profiling of epithelial cells expressing E-cadherin repressors reveals a distinct role for Snail, Slug, and E47 factors in epithelial-mesenchymal transition.

Authors:  Gema Moreno-Bueno; Eva Cubillo; David Sarrió; Héctor Peinado; Socorro María Rodríguez-Pinilla; Sonia Villa; Victoria Bolós; Mireia Jordá; Angels Fabra; Francisco Portillo; José Palacios; Amparo Cano
Journal:  Cancer Res       Date:  2006-10-01       Impact factor: 12.701

3.  Epithelial-mesenchymal transition-derived cells exhibit multilineage differentiation potential similar to mesenchymal stem cells.

Authors:  Venkata Lokesh Battula; Kurt William Evans; Brett George Hollier; Yuexi Shi; Frank C Marini; Ayyakkannu Ayyanan; Rui-Yu Wang; Cathrin Brisken; Rudy Guerra; Michael Andreeff; Sendurai A Mani
Journal:  Stem Cells       Date:  2010-08       Impact factor: 6.277

4.  Cancer stem cells: the challenges ahead.

Authors:  Jan Paul Medema
Journal:  Nat Cell Biol       Date:  2013-04       Impact factor: 28.824

5.  Snail2 is an essential mediator of Twist1-induced epithelial mesenchymal transition and metastasis.

Authors:  Esmeralda Casas; Jihoon Kim; Andrés Bendesky; Lucila Ohno-Machado; Cecily J Wolfe; Jing Yang
Journal:  Cancer Res       Date:  2011-01-01       Impact factor: 12.701

6.  Genetic predisposition directs breast cancer phenotype by dictating progenitor cell fate.

Authors:  Theresa A Proia; Patricia J Keller; Piyush B Gupta; Ina Klebba; Ainsley D Jones; Maja Sedic; Hannah Gilmore; Nadine Tung; Stephen P Naber; Stuart Schnitt; Eric S Lander; Charlotte Kuperwasser
Journal:  Cell Stem Cell       Date:  2011-02-04       Impact factor: 24.633

7.  Signaling between transforming growth factor β (TGF-β) and transcription factor SNAI2 represses expression of microRNA miR-203 to promote epithelial-mesenchymal transition and tumor metastasis.

Authors:  Xiangming Ding; Serk In Park; Laurie K McCauley; Cun-Yu Wang
Journal:  J Biol Chem       Date:  2013-02-27       Impact factor: 5.157

Review 8.  New Insights into the Crossroads between EMT and Stemness in the Context of Cancer.

Authors:  Isabel Fabregat; Andrea Malfettone; Jitka Soukupova
Journal:  J Clin Med       Date:  2016-03-12       Impact factor: 4.241

9.  Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery.

Authors:  Jessica Kao; Keyan Salari; Melanie Bocanegra; Yoon-La Choi; Luc Girard; Jeet Gandhi; Kevin A Kwei; Tina Hernandez-Boussard; Pei Wang; Adi F Gazdar; John D Minna; Jonathan R Pollack
Journal:  PLoS One       Date:  2009-07-03       Impact factor: 3.240

10.  A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells.

Authors:  Ulrike Burk; Jörg Schubert; Ulrich Wellner; Otto Schmalhofer; Elizabeth Vincan; Simone Spaderna; Thomas Brabletz
Journal:  EMBO Rep       Date:  2008-05-16       Impact factor: 8.807

View more
  6 in total

1.  RNA binding protein RBMS3 is a common EMT effector that modulates triple-negative breast cancer progression via stabilizing PRRX1 mRNA.

Authors:  C James Block; Allison V Mitchell; Ling Wu; James Glassbrook; Douglas Craig; Wei Chen; Gregory Dyson; Donald DeGracia; Lisa Polin; Manohar Ratnam; Heather Gibson; Guojun Wu
Journal:  Oncogene       Date:  2021-10-04       Impact factor: 8.756

2.  Molecular Analysis of ZNF71 KRAB in Non-Small-Cell Lung Cancer.

Authors:  Qing Ye; Rehab Mohamed; Duaa Dakhlallah; Marieta Gencheva; Gangqing Hu; Martin C Pearce; Siva Kumar Kolluri; Clay B Marsh; Timothy D Eubank; Alexey V Ivanov; Nancy Lan Guo
Journal:  Int J Mol Sci       Date:  2021-04-04       Impact factor: 6.208

3.  A Multi-Omics Network of a Seven-Gene Prognostic Signature for Non-Small Cell Lung Cancer.

Authors:  Qing Ye; Brianne Falatovich; Salvi Singh; Alexey V Ivanov; Timothy D Eubank; Nancy Lan Guo
Journal:  Int J Mol Sci       Date:  2021-12-25       Impact factor: 5.923

4.  CTCF Expression and Dynamic Motif Accessibility Modulates Epithelial-Mesenchymal Gene Expression.

Authors:  Kelsey S Johnson; Shaimaa Hussein; Priyanka Chakraborty; Arvind Muruganantham; Sheridan Mikhail; Giovanny Gonzalez; Shuxuan Song; Mohit Kumar Jolly; Michael J Toneff; Mary Lauren Benton; Yin C Lin; Joseph H Taube
Journal:  Cancers (Basel)       Date:  2022-01-01       Impact factor: 6.639

5.  Tuning the Cell-Adhesive Properties of Two-Component Hybrid Hydrogels to Modulate Cancer Cell Behavior, Metastasis, and Death Pathways.

Authors:  Melis Isik; Babatunde O Okesola; Cemil Can Eylem; Engin Kocak; Emirhan Nemutlu; Emel Emregul; Matteo D'Este; Burak Derkus
Journal:  Biomacromolecules       Date:  2022-09-22       Impact factor: 6.978

6.  Analysis of immune subtypes across the epithelial-mesenchymal plasticity spectrum.

Authors:  Priyanka Chakraborty; Emily L Chen; Isabelle McMullen; Andrew J Armstrong; Mohit Kumar Jolly; Jason A Somarelli
Journal:  Comput Struct Biotechnol J       Date:  2021-06-17       Impact factor: 7.271

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.